FDA NDC Directory · JSON-LD · Markdown

Regadenoson

NDC 43598-616 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerDr. Reddy's Laboratories Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA213210
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsREGADENOSON ANHYDROUS (.08 mg/mL)
Marketing started20230423
Package count1

External sources

Source: openFDA. Public-domain (CC0).